Carmen Busca
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Correction: Retrospective analysis of sexually transmitted infections among people living with HIV and pre-exposure prophylaxis users in Spain.
Journal: BMC infectious diseases
Published: March 31, 2026
Hepatitis B reactivation in people living with HIV and isolated anti-HBc receiving tenofovir-sparing dual antiretroviral therapy.
Journal: HIV medicine
Published: October 31, 2025
Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study).
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 24, 2025
Triglyceride-glucose index and FIB-4 score in relation to cardiovascular disease risk among people with HIV: a retrospective cohort study.
Journal: Frontiers in medicine
Published: May 30, 2025
Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial).
Journal: The Journal of infection
Published: May 19, 2025
Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial.
Journal: Nature communications
Published: October 31, 2024
Retrospective analysis of sexually transmitted infections among people living with HIV and pre-exposure prophylaxis users in Spain.
Journal: BMC infectious diseases
Published: September 13, 2024
Three-Year Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide as a Switch Strategy in the Real World.
Journal: Open forum infectious diseases
Published: August 21, 2024
Last Updated: 09/26/2026